Signal processing algorithms with unmatched speed and a tiny footprint | Sparca was born out of award-winning imaging software provider, AOS, in 2018. NEWPORT BEACH, Calif.--(BUSINESS WIRE)--ALPHAEON Corporation (“ALPHAEON”), announced today that it has completed a reorganization to simplify its corporate structure. Irvine. [6][7], In January 2020, Alpheon completely reorganized its corporate structure and has split into two business units, AEON Biopharma, Inc. and Alphaeon1 LLC. [3], In July 2014, Alphaeon Corporation acquired Physician Recommended Nutricueticals (PRN), a manufacturer of nutritional supplements. Alphaeon Corporation serves healthcare providers in the self-pay segment; primarily plastic surgery, ophthalmology, dermatology, orthopedics, and cosmetic dentistry. Simplicity from Complexity | Strathspey Crown is a visionary portfolio of transformational businesses, focused on the most complex sectors of healthcare, energy, and technology. Consultez le profil complet sur LinkedIn et découvrez les relations de Claudine, ainsi que des emplois dans des entreprises similaires. [8], Coordinates: .mw-parser-output .geo-default,.mw-parser-output .geo-dms,.mw-parser-output .geo-dec{display:inline}.mw-parser-output .geo-nondefault,.mw-parser-output .geo-multi-punct{display:none}.mw-parser-output .longitude,.mw-parser-output .latitude{white-space:nowrap}33°40′42″N 117°51′9″W / 33.67833°N 117.85250°W / 33.67833; -117.85250, "Strathspey Crown Establishes Alphaeon Corporation", "Plastic surgery CEO: IPO will enhance business", "Company Overview of Strathspey Crown LLC", "Alphaeon buys Physician Recommended Nutriceuticals (PRN) for US$55m", "Alphaeon acquires Clarion Medical Technologies", "ALPHAEON Corporation Completes Reorganization to Simplify its Corporate Structure", https://en.wikipedia.org/w/index.php?title=Alphaeon_Corporation&oldid=970016447, Technology companies of the United States, Creative Commons Attribution-ShareAlike License, Physician Recommended Nutriceutials (PRN), This page was last edited on 28 July 2020, at 18:49. The AOS Anterior solution is transforming the ophthalmic industry, using its 400+ algorithms to create better images, extract more information and analyse more data. Tel: +1-949-260-1700. Rick Taketa, Lead Independent Director of AEON’s Board of Directors and also a manager of Alphaeon1 LLC, said, “We are pleased to see Evolus’s strong market uptake in 2019 and are excited about Evolus’s future prospects. ALPHAEON Corporation a Strathspey Crown company | 2 688 abonnés sur LinkedIn. • As a QA lead reviewed business requirements with business teams and coordinated tasks with … Alphaeon Corporation is a technology company focused in healthcare products and services based in Irvine, California. [4][5], In December 2014, Alphaeon Corporation acquired Clarion Medical Technologies, a medical device and product manufacturer based in Cambridge, Ontario. AEON undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. ALPHAEON Corporation (“ALPHAEON”), announced today that it has completed a reorganization to simplify its corporate structure. ALPHAEON CORPORATION, 4040 Macarthur Boulevard, Newport Beach, CA, 92660, United States 920-306-1794 teamcredit@alphaeon.com As a result of this reorganization the company has split into two business units, each of which will retain the same shareholder base that was in place prior to this split off. ALPHAEON Corporation a Strathspey Crown company Jun 2015 - Sep 2015 4 months - Processed customer complaints, document change control, ingredient and packaging review ALPHAEON has been renamed AEON Biopharma, Inc. (“AEON”), which will now focus on developing its proprietary botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection, as a therapeutic application for debilitating medical conditions. Alphaeon Corporation was founded in July 2013 by former Chief Executive Officer, Robert E. Find company research, competitor information, contact details & financial data for Alphaeon Corporation of Irvine, CA. November 2015 – Present 4 years. ALPHAEON CREDIT is the fastest growing alternative program for patient financing. Claudine a 9 postes sur son profil. ALPHAEON Corporation. NEWPORT BEACH, Calif., May 15, 2019 /PRNewswire/ -- ALPHAEON Corporation announced today that it has agreed to sell approximately 4.0 million shares of common stock in Evolus, Inc. (NASDAQ: EOLS) in an underwritten public offering with Morgan Stanley acting as sole underwriter for the offering. ALPHAEON Corporation a Strathspey Crown company. As a result of this reo We fearlessly innovate, incubate, and invest in disruptive technologies that transform conventional paradigms of scarcity and … Alphaeon Corporation is a technology company focused in healthcare products and services based in Irvine, California. A second unit, Alphaeon1 LLC, will provide a way for the ALPHAEON stockholders to continue to hold the approximately 8.7 million shares of Evolus Inc. (NASDAQ:EOLS) previously held by ALPHAEON, subject to securities law restrictions on resales by affiliates for six months under Rule 144. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support Voir le profil de Claudine Leprince sur LinkedIn, le plus grand réseau professionnel mondial. Get the latest business insights from Dun & Bradstreet. As such, we sought a way for our stockholders to continue to maintain a significant equity stake in Evolus, as we focus operationally on AEON’s critical phase of development. Strathspey Crown Holdings LLC | 2,402 followers on LinkedIn. Alphaeon Corporation serves healthcare providers in the self-pay segment; primarily plastic surgery, ophthalmology, dermatology, orthopedics, and cosmetic dentistry. Alphaeon Corporation was founded in July 2013 by former Chief Executive … Amy Nangle No shares will be sold by Evolus in the offering nor will any of the … Any forward-looking statement made by AEON in this press release is based only on information currently available to it and speaks only as of the date on which such statement is made. AEON Biopharma, Inc. (previously known as ALPHAEON Corporation) focuses on developing its proprietary botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection, for debilitating medical conditions. [1][2] Alphaeon Corporation remains a wholly owned subsidiary of Strathspey Crown LLC, a private equity firm located in Newport Beach, California. Statements in this press release that are not a description of historical fact are forward-looking statements and may be identified by the use of words referencing future events or circumstances such as "expect," "intend," "plan," "anticipate," "believe," and "will," among others. Grant. Newport Beach, Ca. ALPHAEON is a lifestyle healthcare company, committed to partnering with board-certified specialists to bring to market innovative products and servic . We continue to have a positive outlook on the long-term potential of the position held in Evolus for our stockholders. Company profile page for Alphaeon Corp including stock price, company news, press releases, executives, board members, and contact information ALPHAEON Corporation is a social commerce company with the goal of … Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. History. Sparca | 205 followers on LinkedIn. ALPHAEON PRESS CONTACT: Evolus and AEON have always operated independently, and this action now makes the separation of the therapeutic and aesthetic applications of the neurotoxin cleaner and clearer.”. May 2013 - Present7 years 8 months.